Change - Announcement of Appointment::Appointment of Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
OLAM INTERNATIONAL LIMITED
Securities
OLAM INTERNATIONAL LIMITED - SG1Q75923504 - O32
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
30-Aug-2019 17:25:42
Status
New
Announcement Sub Title
Appointment of Independent Non-Executive Director
Announcement Reference
SG190830OTHRDCA1
Submitted By (Co./ Ind. Name)
Michelle Tanya Kwek
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Dr. Joerg Wolle as Independent Non-Executive Director

Additional Details

Date Of Appointment
01/09/2019
Name Of Person
Dr. Joerg Wolle
Age
62
Country Of Principal Residence
Switzerland
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Governance and Nomination Committee (GNC) reviewed the proposed appointment of Dr. Joerg Wolle as an Independent Non-Executive Director and took into consideration the feedback of the Board on its composition and diversity of experience. Consequent to the review by the GNC, the Board carried out its review and assessment of the experience, skillset, qualification and qualities of Dr. Joerg Wolle. The Board also considered the existing composition of the Board, the size of the Board as well as the diversity of experience of the Board. Dr. Wolle is considered by the Board as having possessed extensive business and industry experience that can complement the existing Board. The Board is satisfied that Dr. Wolle will be able to contribute significantly to the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director
Professional qualifications
PhD in Engineering "summa cum laude" 1987
Technical University Chemnitz

Executive Development Program 1994
IMD Lausanne, Switzerland

Stanford Executive Program 1998
GSB Stanford University, Palo Alto, CA, USA
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
Dr. Joerg Wolle is presently Chairman of Kuehne + Nagel International Ltd (since 2016) and Klingelnberg AG (since 2018). He was President and CEO of DKSH Holding Ltd from 2002 to 2017 and became its Chairman from 2017 to 2019. Dr. Wolle was a member of the Supervisory Board of Louis Dreyfus Company B.V. from 2014 to 2018 and a member of the Board of Directors of UBS Ltd from 2006 to 2009 and Diethelm Keller Holding Ltd. from 2004 to 2019.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
DKSH Holding Ltd.
Chairman (2017-2019)
President & CEO (2002-2017)

Diethelm Keller Holding Ltd.
Board Member

Louis Dreyfus Company B.V.
Member, Supervisory Board
Chairman, Compensation, Nomination and Governance Committee
Member, Strategy Committee

Kuehne + Nagel International Ltd.
Board Member
Chairman, Nomination and Compensation Committee
Present
Chairman, Kuehne + Nagel International Ltd.
Chairman, Klingelnberg AG
Board Member, Kuehne Holding Ltd.
Member, Board of Trustees, Kuehne Foundation
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
No
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Dr. Joerg Wolle has had extensive professional experience including being Chairman and Board Member of companies listed on the SIX Swiss Exchange, namely, Kuehne + Nagel International Ltd., Klingelnberg AG, DKSH Holding Ltd. and UBS Ltd. The Governance and Nomination Committee found Dr. Wolle's experience relevant and comparable to the experience of a person who has served as a director of an issuer listed on the Singapore Exchange.

As part of the new director induction program, Dr. Joerg Wolle will also be briefed on the local legal, regulatory and governance requirements as well as the duties of a director.